| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-10 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |